SCORPIUS HOLDINGS INC (SCPX) Stock Price & Overview
NYSEARCA:SCPX • US42237K5083
Current stock price
The current stock price of SCPX is 0.068 USD. Today SCPX is down by -48.48%. In the past month the price decreased by -59.04%. In the past year, price decreased by -78.97%.
SCPX Key Statistics
- Market Cap
- 331.16K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.38
- Dividend Yield
- N/A
SCPX Stock Performance
SCPX Stock Chart
SCPX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SCPX. When comparing the yearly performance of all stocks, SCPX is a bad performer in the overall market: 98.79% of all stocks are doing better.
SCPX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SCPX. SCPX may be in some trouble as it scores bad on both profitability and health.
SCPX Earnings
SCPX Forecast & Estimates
7 analysts have analysed SCPX and the average price target is 5.1 USD. This implies a price increase of 7400% is expected in the next year compared to the current price of 0.068.
For the next year, analysts expect an EPS growth of 97.7% and a revenue growth 63.27% for SCPX
SCPX Groups
Sector & Classification
SCPX Financial Highlights
Over the last trailing twelve months SCPX reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 20.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -72.96% | ||
| ROE | -128.83% | ||
| Debt/Equity | 0.31 |
SCPX Ownership
SCPX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.55 | 354.636B | ||
| AMGN | AMGEN INC | 15.27 | 186.69B | ||
| GILD | GILEAD SCIENCES INC | 15.12 | 164.958B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.34 | 111.326B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.34 | 78.928B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45.97 | 41.441B | ||
| INSM | INSMED INC | N/A | 31.186B | ||
| NTRA | NATERA INC | N/A | 29.449B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 28.041B | ||
| BIIB | BIOGEN INC | 11.65 | 27.895B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.6 | 25.171B | ||
| MRNA | MODERNA INC | N/A | 22.05B | ||
| INCY | INCYTE CORP | 12.33 | 19.252B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SCPX
Company Profile
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in San Antonio, Texas and currently employs 82 full-time employees. The company went IPO on 2013-07-24. The firm couples Current Good Manufacturing Practices (CGMP) biomanufacturing and quality control knowledge with capabilities in immunoassays, molecular assays, and bioanalytical methods to support cell- and gene-based therapies as well as large molecule biologics using American-made equipment, reagents, and materials. The company offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. The firm's CDMO service offerings also include enhanced microbial and mammalian development and manufacturing services.
Company Info
IPO: 2013-07-24
SCORPIUS HOLDINGS INC
1305 E. Houston Street, Building 2
San Antonio TEXAS US
Employees: 83
Phone: 19192407133
SCORPIUS HOLDINGS INC / SCPX FAQ
What does SCPX do?
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in San Antonio, Texas and currently employs 82 full-time employees. The company went IPO on 2013-07-24. The firm couples Current Good Manufacturing Practices (CGMP) biomanufacturing and quality control knowledge with capabilities in immunoassays, molecular assays, and bioanalytical methods to support cell- and gene-based therapies as well as large molecule biologics using American-made equipment, reagents, and materials. The company offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. The firm's CDMO service offerings also include enhanced microbial and mammalian development and manufacturing services.
Can you provide the latest stock price for SCORPIUS HOLDINGS INC?
The current stock price of SCPX is 0.068 USD. The price decreased by -48.48% in the last trading session.
Does SCORPIUS HOLDINGS INC pay dividends?
SCPX does not pay a dividend.
What is the ChartMill technical and fundamental rating of SCPX stock?
SCPX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about SCORPIUS HOLDINGS INC (SCPX) stock?
7 analysts have analysed SCPX and the average price target is 5.1 USD. This implies a price increase of 7400% is expected in the next year compared to the current price of 0.068.
What is the next earnings date for SCPX stock?
SCORPIUS HOLDINGS INC (SCPX) will report earnings on 2025-05-26.